Advertisement
Screener

Innate Pharma SA (IPHA) Form 6-K: Report of foreign private issuer, 2025

1.2 / 5 stars · 6/26 Roast Me

Add as a preferred source on Google

Innate Pharma SA Form 6-K: Report of foreign private issuer

Filings on SEC EDGAR, newest first; amendments sit with their base form. Values are as filed.

  • 2025-12-22: Form 6-K; Period of report 2025-12-22; Description 6-K; Document a251222_6k-iphx251222.htm.
  • 2025-12-11: Form 6-K; Period of report 2025-12-11; Description 6-K; Document a6k-iphx251211.htm.
  • 2025-11-28: Form 6-K; Period of report 2025-11-28; Description 6-K; Document a6k-iphx251128.htm.
  • 2025-11-17: Form 6-K; Period of report 2025-11-17; Description 6-K; Document a6k-iphx250825.htm.
FiledFormPeriod of reportDescriptionDocument
2025-12-226-K2025-12-226-Ka251222_6k-iphx251222.htm
2025-12-116-K2025-12-116-Ka6k-iphx251211.htm
2025-11-286-K2025-11-286-Ka6k-iphx251128.htm
2025-11-176-K2025-11-176-Ka6k-iphx250825.htm
2025-11-136-K2025-11-136-Ka2511136k-iphxincorporated.htm
2025-11-106-K2025-11-106-Ka2511106k-iphxincorporated.htm
2025-11-056-K2025-11-056-Ka6ktemplate-iphnovember5.htm
2025-10-156-K2025-10-146-Ka6k-iphx251014.htm
2025-09-176-K2025-06-306-Kmastercoverpage6k-hypressr.htm
2025-09-176-K2025-06-306-Kinpha-20250630.htm
2025-09-156-K2025-09-156-Ka6k-iphx250915.htm
2025-09-106-K2025-09-106-Ka6k-iphx250910.htm
2025-09-026-K2025-09-026-Ka6k-iphx250902.htm
2025-08-046-K2025-08-046-Ka6k-iphx250801.htm
2025-07-296-K2025-07-296-Ka6k-iphx250728.htm
2025-07-076-K2025-07-046-Ka6k-iphx250704.htm
2025-06-176-K2025-06-176-Ka6k-iphx250617.htm
2025-06-136-K2025-06-136-Ka6k-250613.htm
2025-05-276-K2025-05-276-Ka6k-iphx250527.htm
2025-05-236-K2025-05-236-Ka6k-iphx250523.htm
2025-05-236-K2025-05-236-Ka6k-250523.htm
2025-05-196-K2025-05-196-Ka6k-250519.htm
2025-05-156-K2025-05-156-Ka6k-250515.htm
2025-05-136-K2025-05-136-Ka6k-iphx250513.htm
2025-05-126-K2025-05-126-Ka6k-iphx250512.htm
2025-05-066-K2025-05-066-Ka6k-iphx250506.htm
2025-04-306-K2025-04-306-Ka6k-iphx250430.htm
2025-04-296-K2025-04-296-Ka6k-iphx250429.htm
2025-04-286-K2025-04-286-Ka6k-iphx250428.htm
2025-04-246-K2025-04-246-Ka6k-iphx250424.htm
2025-04-236-K2025-04-236-Ka6k-iphx250423.htm
2025-04-166-K2025-04-166-Ka6k-iphx250416.htm
2025-04-166-K2025-04-166-Ka6k-iphx2504161.htm
2025-04-036-K2025-04-036-Ka6k-iphx250403.htm
2025-03-276-K2025-03-276-Ka6k-iphx250327.htm
2025-03-266-K2025-03-266-Ka6k-iphx250326.htm
2025-03-256-K2025-03-256-Ka6k-iphx250325.htm
2025-03-206-K2025-03-206-Ka6k-iphx2502271.htm
2025-02-276-K2025-02-276-Ka6k-iphx250227.htm
2025-02-186-K2025-02-176-Ka250217_6kincorporated-iphx.htm
2025-01-276-K2025-01-276-Ka6k-iphx250127.htm
2025-01-216-K2025-01-216-Ka6k-iphx250121.htm
2025-01-166-K2025-01-166-Ka6k-iphx250116.htm
2025-01-106-K2025-01-106-Ka6k-iphx250110.htm
Advertisement